Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-027922

Co-Chief Executive Officer sold 4,135 shares at $18.73 ($77,440)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klee Justin B. Co-Chief Executive Officer 2024-03-05 Sale −4,135 $18.73 $77,440 2,959,308 D
Open-market sales · 4,135 sh · avg $18.73 · $77,440
Loading xslF345X05/ownership.xml…